RABBI DSR

RABBI DSR contains Rabeprazole 20 mg + Domperidone 30 mg (Sustained Release). It is used for the management of acidity, GERD, and reflux-related symptoms. Rabeprazole reduces excess stomach acid, while Domperidone helps improve gastric motility and prevents nausea and bloating. This combination provides better symptom control, especially in patients with acid reflux along with fullness or indigestion, offering long-lasting relief with convenient dosing.